Multimedia | VHL Regional Portal

Resources found: 2

Minitaller sobre la aceptación y el uso de las vacunas en el contexto de la seguridad de las mismas

Date: 22/04/2021

Entender cómo piensa, se posiciona y actúa la gente sobre la vacunación es fundamental para informar el desarrollo de estrategias para la aceptación y el uso de las vacunas. La generación y el uso de datos sobre los factores sociales y de comportamiento implicados requiere un conjunto de herramientas -encuestas, guías de entrevistas, herramientas y marcos relacionados- para apoyar la recopil...
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Access to Essential Medicines and Health Technologies, Health Equity, Viral Vaccines/adverse effects, Health Communication, Communication, Health Systems/organization & administration, Social Participation, Vaccine Potency, Risk Groups, Quarantine, Social Isolation, COVID-19, Infodemia

COVID-19​ live Q&A with Dr Mike Ryan and Dr Maria Van Kerkhove. Ask WHO​ of 6 January 2021

Date: 06/01/2021

#AskWHO​ series: This was the live discussion about the COVID-19 pandemic of 6 January 2021 with Dr Mike Ryan, Executive Director of WHO Health Emergencies Programme, and Dr Maria Van Kerkhove, WHO Technical Lead on COVID-19. Questions from the audience were taken.
See more details

Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Social Isolation, Quarantine, Pandemics/prevention & control, Epidemiological Monitoring, Health Communication, Holidays, Americas/epidemiology, Risk Groups, Betacoronavirus/immunology, Viral Vaccines/immunology, Immunization Programs/organization & administration, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Masks, Betacoronavirus/genetics, Pneumonia, Viral/genetics, Coronavirus Infections/genetics, DNA, Viral/genetics, Mutation/genetics, Vaccine Potency, COVID-19